

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRNA | NASDAQ | USD | Real-time | |
MRNA | Mexico | MXN | Delayed | |
0QF | TradeGate | EUR | Delayed | |
0QF | Frankfurt | EUR | Delayed | |
MRNA-RM | Moscow | RUB | Real-time | |
MRNA_KZ | KASE | USD | Delayed | |
MRNA | Lima | USD | Delayed |
By Ahmed Aboulenein and Jeff Mason WASHINGTON (Reuters) - Health officials are considering extending the eligibility for a second COVID-19 vaccine booster dose to people under 50 amid a steady rise...
By Liz Moyer Investing.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer stock rose 0.6% in...
By Josh Smith and Hyonhee Shin SEOUL (Reuters) - North Korea is facing its first confirmed COVID-19 outbreak with no known vaccine programme, sparking new calls for the government to accept aid that...
(Reuters) - Moderna (NASDAQ:MRNA) Inc has made all necessary submissions required by the U.S. Food & Drug Administration for emergency use authorization of its COVID-19 vaccine in adolescents and...
By Manas Mishra (Reuters) - Pfizer Inc (NYSE:PFE)'s $11.6 billion deal for migraine specialist Biohaven Pharmaceutical has kindled expectations on Wall Street that it may usher in more buyouts as...
(Reuters) -Moderna Inc's chief financial officer, Jorge Gomez, departed a day after taking charge, the vaccine maker said on Wednesday, following his former employer disclosing an internal probe...
(Reuters) - Novavax (NASDAQ:NVAX) Inc's shares plunged nearly 20% in premarket trading on Tuesday due to uncertainty over global demand for the company's COVID-19 vaccine following a slow start to...
By Promit Mukherjee and Jennifer Rigby JOHANNESBURG/LONDON (Reuters) -The World Health Organization (WHO) and its COVID-19 vaccine partner Gavi have no immediate plans to buy shots made by Aspen...
FRANKFURT (Reuters) -BioNTech's first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer (NYSE:PFE), but the German biotech firm is...
By Michael Erman and Manas Mishra (Reuters) - COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review